CD4 and non-small cell lung carcinoma: Lastly, with only relevance analysis being performed in the current study, experiments in vitro and in vivo will also be our next step to explore the molecular mechanisms underlying the protective roles of CD4+ T cells in patients with advanced NSCLC receiving chemo-immunotherapy.